Subscribe to our newsletter to receive the latest product updates and special offers

Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#1 / 107 Total
EVO - Evotec SE ADR - Stock Price Chart
TickerEVO [NASD]
CompanyEvotec SE ADR
CountryGermany
IndustryDrug Manufacturers - Specialty & Generic
Market Cap1.86BEPS (ttm)-
P/E-EPS this Y62.81%
Forward P/E67.23EPS next Y139.68%
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B1.54EPS Q/Q-42.33%
Dividend-Sales Q/Q16.51%
Insider Own5.18%Inst Own0.30%
Insider Trans0.00%Inst Trans-
Short Float0.02%EarningsNov 08/b
Analyst Recom1.40Target Price14.03
Avg Volume52.82K52W Range6.83 - 13.49
Evotec SE engages in the discovery and development of new drugs for pharmaceutical and biotechnology companies. It operates through the following segments: EVT Execute and EVT Innovate. The EVT Execute segment provides stand-alone or integrated drug discovery solutions for collaborators targets and programmers on a typical fee-for-service basis or through a variety of commercial structures, which may include performance-based components, such as milestones and royalties. The EVT Innovate develops drug discovery projects, assets and platforms, both internally or through academic collaborations. The company was founded by Manfred Eigen, Karsten Henco, Ulrich Aldag, Freimut Leidenberger, Heinrich Maria Schulte, Rudolf Rigler, and Charles Weissmann on December 8, 1993 and is headquartered in Hamburg, Germany.
VAXX - Vaxxinity Inc - Stock Price Chart
TickerVAXX [NASD, RUT]
CompanyVaxxinity Inc
CountryUSA
IndustryBiotechnology
Market Cap18.49MEPS (ttm)-0.45
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-41.17%
P/S-EPS next 5Y-
P/B1.38EPS Q/Q44.61%
Dividend-Sales Q/Q-
Insider Own64.25%Inst Own9.91%
Insider Trans0.00%Inst Trans0.48%
Short Float9.01%EarningsMar 27/a
Analyst Recom2.00Target Price7.00
Avg Volume574.00K52W Range0.19 - 3.10
Vaxxinity, Inc. is a biotechnology company that aims to democratize health by bringing the efficiency of vaccines to chronic diseases. The company uses its synthetic peptide vaccine platform to harness the immune system and convert the body into its own 'drug factory', stimulating the production of antibodies with a therapeutic effect. Its current pipeline consists of five chronic disease candidates from early to late-stage development across multiple therapeutic areas including Alzheimer's, Parkinson's, migraine and hypercholesterolemia as well as a candidate for COVID-19 prevention. The company was founded by Louis G. Reese IV and Mei Mei Hu in 2014 and is headquartered in Exploration Park, FL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Prime Movers Lab Fund I LP10% OwnerSep 08 '23Sale1.6725,08941,8998,713,663Sep 08 06:05 PM
Prime Movers Lab Fund I LP10% OwnerSep 08 '23Sale1.6722,87238,196831,658Sep 08 06:05 PM
Prime Movers Lab Fund I LP10% OwnerSep 07 '23Sale1.7920,31236,3028,738,752Sep 08 06:05 PM
Prime Movers Lab Fund I LP10% OwnerSep 07 '23Sale1.7918,51633,092834,053Sep 08 06:05 PM
Prime Movers Lab Fund I LP10% OwnerSep 06 '23Sale1.885,3089,9918,759,064Sep 08 06:05 PM
RCON - Recon Technology Ltd - Stock Price Chart
TickerRCON [NASD]
CompanyRecon Technology Ltd
CountryChina
IndustryOil & Gas Equipment & Services
Market Cap3.45MEPS (ttm)-0.25
P/E-EPS this Y29.17%
Forward P/E-EPS next Y76.47%
PEG-EPS past 5Y38.93%
P/S0.36EPS next 5Y-
P/B0.07EPS Q/Q-
Dividend-Sales Q/Q-0.22%
Insider Own1.86%Inst Own11.14%
Insider Trans0.00%Inst Trans-0.67%
Short Float0.04%EarningsOct 27/a
Analyst Recom1.00Target Price10.00
Avg Volume706.81K52W Range0.09 - 0.45
Recon Technology Ltd. engages in providing oilfield services. It operates through the following segments: Automation Product and Software, Equipment and Accessories, Oilfield Environmental Protection, and Platform Outsourcing Services. The Automation Product and Software segment is involved in the sale of automation products specialized equipment when combined with services represent a single performance obligation for the development and construction of a single asset. The Equipment and Accessories segment includes the delivery of standard or customized products and equipment, including automation products, furnaces, and related accessories. The Oilfield Environmental Protection segment focuses on the wastewater treatment products and related service to oilfield and chemical industry companies. The Platform Outsourcing Services segment refers to online platform development, maintenance, and operation services to gas stations around different provinces in China. The company was founded by Guang Qiang Chen, Hong Qi Li, and Shen Ping Yin on August 21, 2007 and is headquartered in Beijing, China.
NCI - Neo-Concept International Group Holdings Ltd. - Stock Price Chart
TickerNCI [NASD]
CompanyNeo-Concept International Group Holdings Ltd.
CountryHong Kong
IndustryApparel Manufacturing
Market Cap-EPS (ttm)-
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B-EPS Q/Q-
Dividend-Sales Q/Q-
Insider Own-Inst Own-
Insider Trans-Inst Trans-
Short Float-Earnings-
Analyst Recom-Target Price-
Avg Volume7.02M52W Range3.84 - 11.39
NCI is a one-stop apparel solution services provider. We offer a full suite of services in the apparel supply chain, including market trend analysis, product design and development, raw material sourcing, production and quality control, and logistics management serving customers located in the European and North American markets through Neo-Concept HK.
ATXI - Avenue Therapeutics Inc - Stock Price Chart
TickerATXI [NASD]
CompanyAvenue Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap4.03MEPS (ttm)-1.78
P/E-EPS this Y58.16%
Forward P/E-EPS next Y9.76%
PEG-EPS past 5Y50.07%
P/S-EPS next 5Y-
P/B1.47EPS Q/Q-93.89%
Dividend-Sales Q/Q-
Insider Own11.82%Inst Own2.79%
Insider Trans-10.55%Inst Trans4.58%
Short Float0.73%EarningsMar 18/a
Analyst Recom1.00Target Price0.75
Avg Volume1.52M52W Range0.11 - 1.25
Avenue Therapeutics, Inc. is a specialty pharmaceutical company, which engages in acquiring, licensing, and commercializing products for use in the intensive care hospital setting. It focuses on the development of intravenous tramadol, a potential alternative that could reduce the use of conventional opioids for patients suffering from acute pain. The company was founded on February 9, 2015 and is headquartered in Bay Harbor Islands, FL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Davidow Robert L10% OwnerDec 11 '23Sale0.14353,00049,60022,000Dec 13 04:02 PM
Davidow Robert L10% OwnerDec 11 '23Sale0.14264,00036,960681,000Dec 13 04:02 PM
Fortress Biotech, Inc.10% OwnerSep 08 '23Buy0.72418,410301,2551,032,390Sep 12 09:02 AM
ROSENWALD LINDSAY A MDDirectorSep 08 '23Buy0.72348,675251,046354,318Sep 12 09:03 AM
NAAS - Naas Technology Inc ADR - Stock Price Chart
TickerNAAS [NASD]
CompanyNaas Technology Inc ADR
CountryChina
IndustrySpecialty Retail
Market Cap73.74MEPS (ttm)-0.80
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S1.65EPS next 5Y24.57%
P/B8.67EPS Q/Q-264.10%
Dividend-Sales Q/Q115.11%
Insider Own0.95%Inst Own12.68%
Insider Trans0.00%Inst Trans-4.69%
Short Float1.66%EarningsMar 28/a
Analyst Recom1.00Target Price4.50
Avg Volume1.21M52W Range0.96 - 12.04
NaaS Technology, Inc. engages in the provision of electric vehicle charging services. The firm maintains an EV charging network in China through its charging network for third-party charging station operators, and the number of public DCFCs (direct current fast charger with 30kW power output or more) connected to its network. The company was founded by Zhen Dai and Yang Wang on July 16, 2013 and is headquartered in Beijing, China.
BNAI - Brand Engagement Network Inc - Stock Price Chart
TickerBNAI [NASD]
CompanyBrand Engagement Network Inc
CountryUSA
IndustrySoftware - Infrastructure
Market Cap115.29MEPS (ttm)-0.00
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B1.46EPS Q/Q-197.91%
Dividend-Sales Q/Q-
Insider Own54.10%Inst Own5.82%
Insider Trans0.00%Inst Trans5.84%
Short Float0.07%Earnings-
Analyst Recom-Target Price-
Avg Volume77.59K52W Range4.15 - 19.75
Brand Engagement Network, Inc. engages in the provision of conversational artificial intelligence assistants with the purpose of transforming engagement and analytics for businesses through security-focused, multimodal communication and human-like artificial intelligence assistants. The firm is also involved in delivering highly personalized, multi-modal artificial intelligence engagement with a focus on industries where there is a massive workforce gap and an opportunity to transform how consumers engage with networks, providers, and brands. The company is headquartered in Jackson, WY.
SBFM - Sunshine Biopharma Inc - Stock Price Chart
TickerSBFM [NASD]
CompanySunshine Biopharma Inc
CountryUSA
IndustryDrug Manufacturers - Specialty & Generic
Market Cap1.02MEPS (ttm)-19.05
P/E-EPS this Y115.79%
Forward P/E0.06EPS next Y466.67%
PEG-EPS past 5Y73.50%
P/S0.04EPS next 5Y-
P/B0.01EPS Q/Q94.97%
Dividend-Sales Q/Q94.94%
Insider Own4.14%Inst Own11.83%
Insider Trans292.78%Inst Trans-
Short Float0.74%EarningsMar 28/b
Analyst Recom1.00Target Price300.00
Avg Volume746.58K52W Range1.15 - 140.00
Sunshine Biopharma, Inc. is a pharmaceutical company, which engages in the research, development, and commercialization of oncology and antiviral drugs. It is also involved in the development and commercialization of science-based nutritional supplements. The firm's product includes treatment for Coronavirus infections and anticancer drugs. The company was founded on August 31, 2006 and is headquartered in New York, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Slilaty Steve N.Chief Executive OfficerMar 04 '24Buy0.10100,00010,000130,000Mar 05 04:05 PM
Slilaty Steve N.Chief Executive OfficerFeb 08 '24Buy0.1020,0002,00030,000Feb 12 04:05 PM
CNVS - Cineverse Corp - Stock Price Chart
TickerCNVS [NASD]
CompanyCineverse Corp
CountryUSA
IndustryEntertainment
Market Cap10.96MEPS (ttm)-0.98
P/E-EPS this Y23.89%
Forward P/E-EPS next Y25.58%
PEG-EPS past 5Y41.24%
P/S0.21EPS next 5Y10.00%
P/B0.27EPS Q/Q-912.00%
Dividend-Sales Q/Q-52.39%
Insider Own15.90%Inst Own8.20%
Insider Trans0.00%Inst Trans-69.35%
Short Float2.74%EarningsFeb 14/a
Analyst Recom1.00Target Price7.75
Avg Volume647.65K52W Range0.94 - 8.40
Cineverse Corp. is a global streaming technology and entertainment company. It owns and operates streaming channels, all powered by its advanced, proprietary technology platform. The firm currently features enthusiast brands for subscription video on demand (SVOD), advertising-based video on demand (AVOD), and free, ad-supported streaming television (FAST) channels. It entertains consumers around the globe by providing premium feature films and television series, enthusiast streaming channels, and technology services to some media, retail, and technology companies. The company was founded by A. Dale Mayo on March 31, 2000 and is headquartered in New York, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Lindsey Mark WayneCFOSep 29 '23Buy1.1510,00011,50018,631Oct 03 08:29 PM
APDN - Applied Dna Sciences Inc - Stock Price Chart
TickerAPDN [NASD]
CompanyApplied Dna Sciences Inc
CountryUSA
IndustryDiagnostics & Research
Market Cap4.08MEPS (ttm)-0.55
P/E-EPS this Y14.47%
Forward P/E-EPS next Y18.46%
PEG-EPS past 5Y45.52%
P/S0.45EPS next 5Y-
P/B0.77EPS Q/Q70.94%
Dividend-Sales Q/Q-83.07%
Insider Own12.32%Inst Own18.63%
Insider Trans0.00%Inst Trans49.85%
Short Float1.82%EarningsFeb 08/a
Analyst Recom1.00Target Price2.25
Avg Volume135.50K52W Range0.28 - 1.86
Applied DNA Sciences, Inc. engages in developing and marketing technologies to produce and detect deoxyribonucleic acid. It operates through the following segments: Therapeutic DNA Production, MDx Testing Services, and DNA Tagging and Security Products and Services. The Therapeutic DNA Production segment offers DNA detection via PCR to provide and develop clinical molecular diagnostics and genetic testing services. The MDx Testing Services segment is involved in performing and developing clinical molecular diagnostic tests and clinical laboratory testing services. The DNA Tagging and Security Products and Services segment includes manufacture and detection of DNA for industrial supply chain security services. The company was founded in 1983 and is headquartered in Stony Brook, NY.
1234561011